<DOC>
	<DOCNO>NCT00659256</DOCNO>
	<brief_summary>This study examine effect treatment hepatitis C atherosclerosis , harden artery . Hepatitis C disease liver cause virus cause permanent damage organ . Treatment clear virus least half patient reduce risk serious complication disease . Atherosclerosis accumulation cholesterol fat artery narrow blood vessel , lead chest pain , heart attack stroke . Because liver control cholesterol fat level blood , hepatitis C infection may risk factor atherosclerosis increase cholesterol fat blood vessel . Treatment hepatitis C may reduce risk atherosclerosis consequence . This study determine effect hepatitis C treatment rate atherosclerosis narrow blood vessel risk heart attack stroke . Patients 30 year age old current past infection hepatitis C may eligible study . Participants undergo follow test procedure : - Questionnaires regard risk factor heart disease stroke - Measurements blood pressure , heart rate , weight , height , waist hip - Blood test - CT scan ultrasound test measure degree blood vessel harden narrowing heart neck region</brief_summary>
	<brief_title>Hepatitis C Treatment Atherosclerosis</brief_title>
	<detailed_description>Hepatitis C virus ( HCV ) infection associate change lipid metabolism liver peripheral blood . Patients chronic hepatitis C infection tend low level cholesterol LDL-cholesterol . These level increase many patient treatment successful eradication virus . However , know whether increase associate increase cardiovascular risk thus may increase risk atherosclerotic disease . To determine whether eradication HCV affect atherosclerosis progression , propose examine 200 patient chronic hepatitis C marker atherosclerosis risk complication . Up 100 patient clear HCV recover match compare patient fail respond continue chronic hepatitis C. The atherosclerosis assessment include careful history cardiovascular risk factor , battery blood test lipid level relevant biomarkers follow specialized imaging test carotid coronary artery , include ultrasound image intima-media thickness carotid artery computerize axial tomography heart coronary artery . The primary end point assessment difference maximal carotid intima medium thickness secondary end point include difference coronary artery calcium score , Framingham risk score measurement atherosclerosis . This cross-sectional study set stage formal prospective assessment cardiovascular risk factor evidence coronary cerebrovascular disease among patient treat antiviral agent .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<criteria>INCLUSION CRITERIA : Age equal great 30 year , male female Written inform consent All ethnicities Viral hepatitis status : Cases : History chronic hepatitis C define past positivity serum HCVRNA , HCV antibody elevate serum alanine aspartate aminotransferase level least 6 month start treatment Genotype 1 , 2 3 Absence detectable serum HCVRNA PCR screen visit previous test , least 3 month apart . Both test perform least 24 week cessation therapy Past treatment interferon alfa ( standard pegylated ) least 12 week At least 12 month end interferon treatment Normal liver enzymes screen visit Genotype 1 control : Detectable serum HCVRNA screen visit Past treatment interferon alfa ( standard pegylated ) least 12 week At least 12 month end interferon treatment Age ( difference less equal 3 year ) , sex racematched genotype 1 case Genotype 2 3 control : Detectable serum HCVRNA screen visit If previously treat interferon alfa ( standard pegylated ) least 12 month elapsed end treatment Age ( difference less equal 3 year ) , sex , race genotypematched genotype 2 3 case EXCLUSION CRITERIA : Pregnancy lactation History clinical atherosclerotic disease manifest : Ischemic cerebrovascular accident ( CVA ) , transient ischemic accident ( TIA ) radiological evidence stroke . Proven coronary artery disease history myocardial infarction , need coronary angioplasty coronary artery bypass graft , anginal syndrome confirmatory stress test cardiac imaging . Symptomatic peripheral vascular disease , history angioplasty surgical bypass . History carotid artery surgery angioplasty Patients overt atherosclerotic disease include first manifestation disease appear least 3 year cessation interferon treatment . Control patient never treat past include overt manifestation atherosclerosis . Diabetes mellitus unless fast blood sugar maintain within normal limit HBA1C le 7 without need pharmacologic intervention Hypertension unless blood pressure maintain great 6 month within normal limit without need pharmacologic intervention Current treatment cholesterol lower medication Chronic renal failure ( creatinine clearance le 50 ml ) Known HIV infection HCV genotype 4 , 5 , 6 mixed infection . Other cause liver disease apart hepatitis C ( hepatitis B , alcoholic liver disease , NASH , autoimmune hepatitis , PBC etc. ) . Bland , nonalcoholic hepatic steatosis constitute exclusion criterion History trauma neck , surgery deformity preclude sonographic visualization carotid artery Inability sign understand inform consent form A contraindication unwillingness undergo coronary calcium score CT scan exclusion criterion , primary endpoint , long participant willing undergo IMT measurement .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 24, 2015</verification_date>
	<keyword>Hepatitis C Virus</keyword>
	<keyword>Atherosclerosis</keyword>
	<keyword>Intima-Media Thickness</keyword>
	<keyword>Coronary Artery Calcium Score</keyword>
	<keyword>Hepatitis C</keyword>
</DOC>